These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7572587)

  • 1. Efficacy of pindolol for treatment of vasovagal syncope.
    Cohen MB; Snow JS; Grasso V; Lehnert L; Goldner BG; Jadonath RL; Cohen TJ
    Am Heart J; 1995 Oct; 130(4):786-90. PubMed ID: 7572587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of pindolol for treatment of neurocardiogenic syncope.
    Nair N; Padder FA; Kutalek SP; Kantharia BK
    Am J Cardiol; 2004 Nov; 94(9):1189-91. PubMed ID: 15518620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of beta-adrenergic blockader therapy in vasovagal syncope reproduced by head-up tilt test].
    Blanc JJ; Corbel C; Mansourati J; Genet L
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1453-7. PubMed ID: 1684700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
    Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
    Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
    Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.
    Grubb BP; Temesy-Armos P; Hahn H; Elliott L
    Am J Med; 1991 Jan; 90(1):6-10. PubMed ID: 1670907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicenter study on treatment of autonomous nerve-mediated syncope in children with beta-receptor blocker].
    Chen L; DU JB; Zhang QY; Wang C; DU ZD; Wang HW; Tian H; Chen JJ; Wang YL; Hu XF; Li WZ; Han L
    Zhonghua Er Ke Za Zhi; 2007 Dec; 45(12):885-8. PubMed ID: 18339272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal profile before and after beta-blockade in patients with neurocardiogenic syncope.
    Roul G; Riehl-Aleil V; Germain P; Bareiss P
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):1020-30. PubMed ID: 10456630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
    Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test.
    Sheldon R; Rose S; Flanagan P; Koshman ML; Killam S
    Am J Cardiol; 1996 Sep; 78(5):536-9. PubMed ID: 8806338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A
    Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with recurrent syncope of unknown cause in the absence of organic heart disease and relation to results of baseline tilt table testing.
    Gatzoulis K; Sideris S; Theopistou A; Sotiropoulos H; Stefanadis C; Toutouzas P
    Am J Cardiol; 2003 Oct; 92(7):876-9. PubMed ID: 14516899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
    Biffi M; Boriani G; Sabbatani P; Bronzetti G; Frabetti L; Zannoli R; Branzi A; Magnani B
    Heart; 1997 Mar; 77(3):268-72. PubMed ID: 9093048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope.
    Lafuente EA; Martínez LC; Moguel JO; David RN; García JD; Tejeda AO; Reyes PH; González VR
    Arch Med Res; 2004; 35(5):416-20. PubMed ID: 15610912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different treatment strategies for neurocardiogenic syncope.
    Natale A; Sra J; Dhala A; Wase A; Jazayeri M; Deshpande S; Blanck Z; Akhtar M
    Pacing Clin Electrophysiol; 1995 Apr; 18(4 Pt 1):655-62. PubMed ID: 7596849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.
    Moya A; Permanyer-Miralda G; Sagrista-Sauleda J; Carne X; Rius T; Mont L; Soler-Soler J
    J Am Coll Cardiol; 1995 Jan; 25(1):65-9. PubMed ID: 7798528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
    Alegria JR; Gersh BJ; Scott CG; Hodge DO; Hammill SC; Shen WK
    Am J Cardiol; 2003 Jul; 92(1):82-4. PubMed ID: 12842256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.